Selected article for: "asthma pathogenesis and chronic obstructive disease"

Author: Crespo-Lessmann, Astrid; Juárez-Rubio, Cándido; Plaza-Moral, Vicente
Title: Role of toll-like receptors in respiratory diseases
  • Cord-id: l8q7d14h
  • Document date: 2010_5_18
  • ID: l8q7d14h
    Snippet: There has been growing interest in the last 10 years in the study of innate immunity, in particular because of the possible role that toll-like receptors (TLR) may play in the pathogenesis of some respiratory diseases including, asthma, chronic obstructive pulmonary disease, and infections. TLR are a family of type 1 transmembrane proteins, responsible for recognising molecular patterns associated with pathogens (PAMP, pathogen-associated molecular patterns), and expressed by a broad spectrum of
    Document: There has been growing interest in the last 10 years in the study of innate immunity, in particular because of the possible role that toll-like receptors (TLR) may play in the pathogenesis of some respiratory diseases including, asthma, chronic obstructive pulmonary disease, and infections. TLR are a family of type 1 transmembrane proteins, responsible for recognising molecular patterns associated with pathogens (PAMP, pathogen-associated molecular patterns), and expressed by a broad spectrum of infectious agents. This recognition leads to a quick production of cytokines and chemokines which provides a long-lasting adaptive response to the pathogen. At present, it is considered //It is currently considered that the administration of drugs which modulate the activity of these receptors upwards or downwards may represent major therapeutic progress for handling these diseases. The aim of this review is to describe the different TLS, define their possible role in the pathogenesis of the main respiratory diseases and finally, speculate over the therapeutic possibilities which their modulation, agonist or antagonist, offers as possible therapeutic targets.

    Search related documents:
    Co phrase search for related documents
    • activation production and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • activation production and lrr leucine rich repeat: 1
    • activator signal transducer and lps lipopolysaccharide: 1, 2, 3, 4, 5
    • acute exposure and lps lipopolysaccharide: 1, 2
    • acute inflammation and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute pulmonary injury and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8
    • acute respiratory distress and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress and lrr leucine rich repeat: 1
    • acute respiratory distress development and lps lipopolysaccharide: 1
    • acute respiratory distress syndrome and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lrr leucine rich repeat: 1
    • acute respiratory distress syndrome cause and lps lipopolysaccharide: 1, 2
    • acute respiratory syndrome and lps lipopolysaccharide: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lrr leucine rich repeat: 1
    • adaptor molecule and lps lipopolysaccharide: 1
    • adaptor protein and lps lipopolysaccharide: 1, 2, 3
    • adaptor protein and lrr leucine rich repeat: 1